The Tribunal upheld the OFT’s decision that Genzyme had abused its dominant position by imposing a margin squeeze. However, the Tribunal found that the OFT had not proved that Genzyme’s practice of bundling the supply of the relevant drug with home care services was itself abusive and accordingly reduced the size of the penalty imposed.
This is an unofficial summary prepared by the Registry of the Competition Appeal Tribunal.
